InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Discover the full record of transactions filed by Taylor Stacy L, Vice-Président. Officer active across 1 companies, notably Adaptive Biotechnologies Corp. Aggregated, 12 filings have been logged. Total volume traded: €25k. The latest transaction was disclosed on 8 March 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations12 total
€25,1332,387 shares@ €10.52890.0012% mcap13.3% of flow
Common Stock
SEC:0001209191-22-018095:0·
061,779 shares0
Common Stock
SEC:0001209191-22-017397:0·
€58,78310,130 shares@ €5.80280.0029% mcap71.8% of flow
Common Stock
SEC:0001209191-21-071194·
€58,78310,130 shares@ €5.80280.0029% mcap31.1% of flow
Common Stock
SEC:0001209191-21-071194:0·
€2,738495 shares@ €5.53040.0001% mcap3.3% of flow
Common Stock
SEC:0001209191-21-055367·
€2,738495 shares@ €5.53040.0001% mcap1.4% of flow
Common Stock
SEC:0001209191-21-055367:0·
€6,8551,042 shares@ €6.57850.0003% mcap8.4% of flow
Common Stock
SEC:0001209191-21-044630·
€6,8551,042 shares@ €6.57850.0003% mcap3.6% of flow
Common Stock
SEC:0001209191-21-044630:0·
€6,8161,041 shares@ €6.54720.0003% mcap8.3% of flow
Common Stock
SEC:0001209191-21-042291·
€6,8161,041 shares@ €6.54720.0003% mcap3.6% of flow
Common Stock
SEC:0001209191-21-042291:0·
€6,7021,042 shares@ €6.43190.0003% mcap3.5% of flow
Common Stock
SEC:0001209191-21-029626:0·
€6,7021,042 shares@ €6.43190.0003% mcap8.2% of flow
Common Stock
SEC:0001209191-21-029626·
12 of 12 declarations
About Taylor Stacy L
Stacy L. Taylor is the Senior Vice President and General Counsel at Adaptive Biotechnologies Corp. She is responsible for the company's legal and compliance matters. Her expertise in business law and risk management enables her to contribute to the legal strategy and protect Adaptive's interests.
